Identification of suspected cases

  • Infantile spasms must be differentiated from paroxysmal non-epileptic disorders (PNED) using home video recording.
  • The family should be instructed to record suspicious episodes; It is key to differential diagnosis.
  • High risk case: Hospital admission for complementary tests.
  • Low risk case: Telematic or in-person consultation with video recording follow-up.

Diagnosis

  • Gold standard: ictal EEG with finding of hypsarrhythmia (confirmed diagnosis).
  • In the absence of hypsarrhythmia, at least one clinical episode is required to confirm.
  • Frequent episodes facilitate diagnosis; Low frequencies need prolonged EEG.
  • The electrodecrement It helps differentiate epileptic spasms from events that do not require aggressive treatment.
  • Mandatory neuroimaging (MRI) after diagnosis: to guide etiology (e.g. tuberous sclerosis) and guide treatment.
Image 1: Presentations of tetracosactide (Nuvachten and Synachten depot) in doses of 1 mg/ml. Therapeutic choice in Europe for treatment with ACTH.

Treatment

  • First line: ACTH, vigabatrin or corticosteroids.
  • ACTH: Low doses (e.g. 0.05 mg/kg/d) are equally effective as high doses; duration 2 weeks with taper. Presentation of choice in Europe: tetracosactide (1 mg/ml, IM).
  • Vigabatrin: Initial dose 50 mg/kg/d, target 100–150 mg/kg/d in 2 doses. Duration: 6 months. Key risk: retinal toxicity (21–34% with treatment >6 months).
  • Valproic acid: Treatment of choice to maintain remission. Monitoring: hepatotoxicity and periodic hematologies.
Source details

De Arce Portillo et al. (2010): 58% response to vigabatrin; >80% seizure free with ACTH. Poor prognosis with onset before 4 months, symptomatic condition, neonatal or prenatal history.

From D'Alonzo et al. (2017): Low doses of ACTH are as effective as high doses; Oral prednisone (40–60 mg/day) for 14 days effective and well tolerated.

DePavone et al. (2020): West syndrome is a spectrum with genetic, structural, metabolic and unknown causes; It is considered a spectrum disorder.

Essential keys: Early diagnosis and rapid treatment improve the prognosis. MRI and metabolic/genetic tests are key after confirmation.